Challenges for the Application and Development of Omics Health Technologies in Developing Countries
Version of Record online: 18 OCT 2012
© 2012 Wiley Periodicals, Inc.
Drug Development Research
Special Issue: Impact of Omics on Drug Discovery and Development. Part I
Volume 73, Issue 7, pages 447–451, November 2012
How to Cite
Huzair, F. and Borda-Rodriguez, A. (2012), Challenges for the Application and Development of Omics Health Technologies in Developing Countries. Drug Dev. Res., 73: 447–451. doi: 10.1002/ddr.21036
- Issue online: 21 NOV 2012
- Version of Record online: 18 OCT 2012
- global justice;
- developing countries;
Omics technologies and particular applications for diagnostics and pharmacogenomics, can potentially identify disease risk, reduce disease burden, and provide better and more cost-effective health care. International institutions have recognized that global justice necessitates equity of access to medical technologies for developing and well as developed countries. The promise of the omics technologies may remain unfulfilled for developing countries unless capacities for exploitation and integration are created. These capacities are those that enable contribution efforts to upstream data collection and innovation, and downstream governance and regulation.